Key findings

One randomised controlled trial (RCT) and one single-arm trial found that the OneTouch digital system improved glycaemic control as measured by HbA1c. 

Two pilot studies in NHSScotland proved the feasibility of using the OneTouch digital system in a clinical setting and led to a reduction in face to face appointments by use of remote consultations.

The blood glucose testing strips used with the OneTouch digital system are cheaper than the strips used for other ‘premium’ blood glucose meters, based on 2019 Scottish Drug Tariff data. 

What were we asked to look at?

We were asked to provide a high level overview of the OneTouch digital system which includes the following technologies: OneTouch Verio Flex™ blood glucose meter; OneTouch Reveal® smart app; OneTouch Reveal® cloud; OneTouch Reveal® web app; and the LifeScan Inc. Application Programming Interface.

The clinician only requires an internet connection and a web browser to use the OneTouch digital system. Additional digital infrastructure is not required.

Why is this important?

Blood glucose meters are self-monitoring devices that aim to improve glycaemic control by measuring blood glucose levels and facilitating improved understanding of blood glucose targets. Currently in NHSScotland, there is no way to share these data in real-time with clinicians. Instead reports are generated and shared with clinicians at a later date, which does not allow monitoring and communication between clinician and patient in real-time.

The OneTouch digital system allows real-time sharing and monitoring of blood glucose data via a smartphone app and dedicated data cloud.

The OneTouch digital system is the first third party real-time data sharing platform to be Integrated into NHSScotland and its unique Application Programming Interface allows the NHSScotland to retain ownership of the data.

Referred by 

My LifeScan Inc, the manufacturer of the technology